C07D 309/22
Radicals substituted by oxygen atoms
C07D309/22 (Radicals substituted by oxygen atoms) appears on 100 US grants and 71 published applications in this corpus.
Search patents in C07D- Granted patents
- 100
- Published applications
- 71
- Assignees
- 68
- Inventors
- 367
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 7 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 5 |
| 2006 | 2 | 3 |
| 2007 | 3 | 5 |
| 2008 | 4 | 1 |
| 2009 | 2 | 4 |
| 2010 | 4 | 5 |
| 2011 | 1 | 3 |
| 2012 | 2 | 3 |
| 2013 | 4 | 1 |
| 2014 | 0 | 1 |
| 2015 | 4 | 5 |
| 2016 | 4 | 1 |
| 2017 | 1 | 3 |
| 2018 | 2 | 3 |
| 2019 | 3 | 3 |
| 2020 | 2 | 8 |
| 2021 | 3 | 3 |
| 2022 | 2 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 5 |
| 2025 | 2 | 3 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Odorants and compositions comprising odorants25 Nov 2025US 12,480,070 B2S H Kelkar and Company Limited
- WDR5-MYC inhibitors26 Aug 2025US 12,398,097 B2Vanderbilt University
- Biaryl kinase inhibitors20 Aug 2024US 12,065,437 B2Bristol-Myers Squibb Company
- Pyranoquinazoline derivatives and naphthopyran derivatives1 Nov 2022US 11,485,812 B2Kanto Kagaku Kabushiki Kaisha
- Polysubstituted benzene, preparation method thereof, and method of using the same5 Jul 2022US 11,376,228 B2Genifarm Laboratories Inc
- Rxfp1 agonists28 Aug 2025US 2025/0268903 A1Bristol-Myers Squibb Company
- Rxfp1 agonists10 Jul 2025US 2025/0221966 A1Bristol-Myers Squibb Company
- Aminoheteroaryl kinase inhibitors2 Jan 2025US 2025/0002480 A1Allorion Therapeutics Inc
- Compound for degradation of bcl-2 family proteins and medical application thereof12 Dec 2024US 2024/0408085 A1Xizang Haisco Pharmaceutical Co., Ltd.
- Biaryl kinase inhibitors31 Oct 2024US 2024/0360131 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture88US 7,417,032 B2Boehringer Ingelheim International GmbH · 2008
- Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments78US 4,839,369 ARorer Pharmaceutical Corporation · 1989
- Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments70US 4,631,287 AUSV Pharmaceutical Corporation · 1986
- Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments53US 4,725,619 AUSV Pharmaceutical Corporation · 1988
- Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments49US 4,728,668 AUSV Pharmaceutical Corporation · 1988